Paper
In vitro autoradiographic localization of amylin binding sites in rat brain
Published Sep 1, 1994 · P. Sexton, G. Paxinos, M. Kenney
Neuroscience
Q2 SJR score
280
Citations
11
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Amylin binding sites in rat brain are present in areas potentially involved in appetite, fluid and electrolyte homeostasis, autonomy function, and mood regulation.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin
Two receptors with high affinity for salmon calcitonin were cloned from rat brain, with Cla receptor found in skeletal muscle, kidney, and lung, and Clb predominantly found in brain.
1993·104citations·K. Albrandt et al.·FEBS Letters
FEBS Letters
Identification of brain isoforms of the rat calcitonin receptor.
Clone C1b is a novel brain isoform of the rat calcitonin receptor with different affinity for calcitonin analogs due to an altered second extracellular domain.
1993·135citations·P. Sexton et al.·Molecular endocrinology
Molecular endocrinology
Anorexia following the systemic injection of amylin
Intravenous amylin injections in rats cause brief anorexia and hyperglycemia, potentially due to neurochemical changes and hyperglycemia.
1993·81citations·W. Chance et al.·Brain Research
Brain Research
Structure and biology of amylin.
Amylin is a 37 amino acid peptide secreted from pancreatic -cells, with potential roles in insulin-dependent diabetes and insulin-resistant conditions, and may contribute to metabolic diseases.
1993·106citations·T. Rink et al.·Trends in pharmacological sciences
Trends in pharmacological sciences
Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts
Amylin inhibits bone resorption by directly affecting osteoclast motility through mechanisms distinct from those of calcitonin, potentially through different receptor subtypes.
1993·104citations·A. Alam et al.·Experimental Physiology
Experimental Physiology
Citations
Central nervous system pathways targeted by amylin in the regulation of food intake.
Amylin and related peptide salmon calcitonin target various central nervous system pathways to regulate food intake, potentially enhancing obesity treatment with cagrilintide.
2024·0citations·Mohamed K. Hankir et al.·Biochimie
Biochimie
Changes in hippocampal volume, synaptic plasticity and amylin sensitivity in an animal model of type 2 diabetes are associated with increased vulnerability to amyloid-beta in advancing age
A type 2 diabetes-like state increases the vulnerability of the hippocampus to the debilitating effects of amyloid-beta in aging mice, partly due to changes in amylin receptor signaling.
2024·0citations·Melih Tarhan et al.·Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience
Amylin-like immunoreactivity in the extra-islet peptide YY-producing and glucagon-immunoreactive cells in Japanese quail pancreas.
Amylin and peptide YY co-secreted from extra-islet cells in Japanese quail pancreas may play a role in insulin and glucagon release regulation and food intake modulation through the central nervous system.
2024·0citations·Bonten Yanagida et al.·Anatomia, histologia, embryologia
Anatomia, histologia, embryologia
Novel mechanisms involved in leptin sensitization in obesity.
Leptin sensitizers, which act on multiple levels of the gastrointestinal-brain axis, can improve leptin sensitivity in obesity by interacting with various endocrine factors from the gastrointestinal-brain axis.
2024·5citations·V. Pena-León et al.·Biochemical pharmacology
Biochemical pharmacology
The processing intermediate of human amylin, pro-amylin(1-48), has in vivo and in vitro bioactivity.
Pro-amylin(1-48) has biological activity and may play a role in the development of future amylin-based drugs.
2024·2citations·Giulia Mazzini et al.·Biophysical chemistry
Biophysical chemistry